Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1007/S10545-011-9336-2 | ||||
| Año | 2011 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Conclusion These data highlight important differences in MPS I patients between Latin America and ROW in terms of phenotypic distribution, clinical manifestations, and treatment practices.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Munoz-Rojas, Maria Veronica | Mujer | |
| 2 | Bay, Luisa | Mujer |
Hosp Nacl Pediat JP Garrahan - Argentina
Fundacion Hospital de Pediatria Professor Dr. Juan P. Garrahan - Argentina |
| 3 | Sanchez, Luz | - |
Hosp Especialidades UMAE 25 - México
UMAE 25 - México |
| 4 | van Kuijck, Marcel | Hombre |
Genzyme Corp - Brasil
Latin America Group - Brasil |
| 5 | Ospina, Sandra | Mujer |
Univ Rosario - Colombia
Universidad del Rosario - Colombia |
| 6 | CABELLO-ANDRADE, JUAN FRANCISCO | Hombre |
Universidad de Valparaíso - Chile
Universidad de Chile - Chile Facultad de Medicina - Chile |
| 7 | Martins, Ana Maria | Mujer |
Univ Fed Sao Paulo - Brasil
Universidade Federal de São Paulo - Brasil |
| Agradecimiento |
|---|
| The authors thank the patients and physicians who participate in the MPS I Registry from the Latin America region as well as worldwide. The authors also acknowledge the contributions of the MPS I Registry team at Genzyme Corporation, which provided support for medical writing (Laura Artiles-Carloni) and data analyses (Jessica Kong, Lakshmi Rangachari, Gregory Fagan, and Asif Karbhari). |